CN100490864C - Yin-nourishing fatigue-relieving capsules - Google Patents
Yin-nourishing fatigue-relieving capsules Download PDFInfo
- Publication number
- CN100490864C CN100490864C CNB2006100193832A CN200610019383A CN100490864C CN 100490864 C CN100490864 C CN 100490864C CN B2006100193832 A CNB2006100193832 A CN B2006100193832A CN 200610019383 A CN200610019383 A CN 200610019383A CN 100490864 C CN100490864 C CN 100490864C
- Authority
- CN
- China
- Prior art keywords
- vitamin
- vitis viniferae
- semen vitis
- soybean isoflavone
- viniferae extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 15
- 239000000284 extract Substances 0.000 claims abstract description 18
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 claims abstract description 16
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims abstract description 16
- 235000008696 isoflavones Nutrition 0.000 claims abstract description 16
- 244000068988 Glycine max Species 0.000 claims abstract description 14
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 14
- 239000001913 cellulose Substances 0.000 claims abstract description 12
- 229920002678 cellulose Polymers 0.000 claims abstract description 12
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 22
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 16
- 210000000582 semen Anatomy 0.000 claims description 16
- 235000009392 Vitis Nutrition 0.000 claims description 15
- 241000219095 Vitis Species 0.000 claims description 15
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 11
- 229930003268 Vitamin C Natural products 0.000 claims description 11
- 235000019154 vitamin C Nutrition 0.000 claims description 11
- 239000011718 vitamin C Substances 0.000 claims description 11
- 235000005911 diet Nutrition 0.000 claims description 10
- 230000000378 dietary effect Effects 0.000 claims description 10
- 229930003427 Vitamin E Natural products 0.000 claims description 8
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 8
- 235000019165 vitamin E Nutrition 0.000 claims description 8
- 229940046009 vitamin E Drugs 0.000 claims description 8
- 239000011709 vitamin E Substances 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 4
- 208000019622 heart disease Diseases 0.000 abstract description 4
- 206010020772 Hypertension Diseases 0.000 abstract description 3
- 229940087559 grape seed Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 17
- 230000001568 sexual effect Effects 0.000 description 14
- 230000036541 health Effects 0.000 description 11
- 239000000262 estrogen Substances 0.000 description 8
- 235000013402 health food Nutrition 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 229940011871 estrogen Drugs 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- 230000032683 aging Effects 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 235000013305 food Nutrition 0.000 description 5
- 239000003075 phytoestrogen Substances 0.000 description 5
- 206010020751 Hypersensitivity Diseases 0.000 description 4
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 208000026935 allergic disease Diseases 0.000 description 3
- 230000007815 allergy Effects 0.000 description 3
- 235000013325 dietary fiber Nutrition 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 208000029742 colonic neoplasm Diseases 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000002124 endocrine Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 238000005453 pelletization Methods 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 201000001514 prostate carcinoma Diseases 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 229960003604 testosterone Drugs 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- NWXMGUDVXFXRIG-WESIUVDSSA-N (4s,4as,5as,6s,12ar)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O NWXMGUDVXFXRIG-WESIUVDSSA-N 0.000 description 1
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- 229930195573 Amycin Natural products 0.000 description 1
- 208000012219 Autonomic Nervous System disease Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 244000293323 Cosmos caudatus Species 0.000 description 1
- 235000005956 Cosmos caudatus Nutrition 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 240000004859 Gamochaeta purpurea Species 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 206010021703 Indifference Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 208000000277 Splenic Neoplasms Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000000895 acaricidal effect Effects 0.000 description 1
- 239000000642 acaricide Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 229940025084 amphetamine Drugs 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000004706 cardiovascular dysfunction Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000003026 cod liver oil Substances 0.000 description 1
- 235000012716 cod liver oil Nutrition 0.000 description 1
- 108010052008 colla corii asini Proteins 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229940035811 conjugated estrogen Drugs 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 235000005118 dietary health Nutrition 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- QTTMOCOWZLSYSV-QWAPEVOJSA-M equilin sodium sulfate Chemical compound [Na+].[O-]S(=O)(=O)OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4C3=CCC2=C1 QTTMOCOWZLSYSV-QWAPEVOJSA-M 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- -1 heterocycle polyphenol compound Chemical class 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 108091008039 hormone receptors Proteins 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 238000007443 liposuction Methods 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 239000002417 nutraceutical Substances 0.000 description 1
- 235000021436 nutraceutical agent Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 238000004091 panning Methods 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 229920002414 procyanidin Polymers 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 201000002471 spleen cancer Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 208000012991 uterine carcinoma Diseases 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/77—Polymers containing oxygen of oxiranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- General Chemical & Material Sciences (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Nutrition Science (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Embodiment 1 | Embodiment 2 | Embodiment 3 | Embodiment 4 | |
Dietary cellulose | 78 | 27 | 19 | 52.4 |
Soybean isoflavone | 10 | 67 | 80 | 35 |
Semen Vitis viniferae extract | 12 | 6 | 1 | 12 |
Vitamin C | 0 | 0 | 0 | 0.3 |
Vitamin E | 0 | 0 | 0 | 0.3 |
Claims (2)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100193832A CN100490864C (en) | 2006-06-16 | 2006-06-16 | Yin-nourishing fatigue-relieving capsules |
PCT/CN2007/001649 WO2007147319A1 (en) | 2006-06-16 | 2007-05-21 | Yin-nourishing capsule |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100193832A CN100490864C (en) | 2006-06-16 | 2006-06-16 | Yin-nourishing fatigue-relieving capsules |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1895469A CN1895469A (en) | 2007-01-17 |
CN100490864C true CN100490864C (en) | 2009-05-27 |
Family
ID=37608210
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006100193832A Expired - Fee Related CN100490864C (en) | 2006-06-16 | 2006-06-16 | Yin-nourishing fatigue-relieving capsules |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN100490864C (en) |
WO (1) | WO2007147319A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014083577A2 (en) | 2012-11-27 | 2014-06-05 | Tata Global Beverages Limited | Beverage with heart aid functional ingredients and process thereof |
CN103300363B (en) * | 2013-05-29 | 2014-10-29 | 湖北阳光医药科技有限公司 | Anti-fatigue traditional Chinese medicine capsule and preparation method thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1559420A (en) * | 2004-03-02 | 2005-01-05 | 北京科信必成医药科技发展有限公司 | Medicne tablets with function of delaying senility, and prepn. method therefor |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1190192C (en) * | 2002-12-30 | 2005-02-23 | 杜越新 | Capsule agent with grape-seed extracts as raw material |
JP2005068060A (en) * | 2003-08-22 | 2005-03-17 | Nrl Pharma Inc | Pharmaceutical composition containing lactoferrin and method for producing processed food containing lactoferrin |
CN1515251A (en) * | 2003-08-25 | 2004-07-28 | 莉 马 | Composition with function of beautifying face and its application |
US20050260285A1 (en) * | 2004-05-21 | 2005-11-24 | Dimateeo-Leggio Giovina | Healthy prostate formula |
-
2006
- 2006-06-16 CN CNB2006100193832A patent/CN100490864C/en not_active Expired - Fee Related
-
2007
- 2007-05-21 WO PCT/CN2007/001649 patent/WO2007147319A1/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1559420A (en) * | 2004-03-02 | 2005-01-05 | 北京科信必成医药科技发展有限公司 | Medicne tablets with function of delaying senility, and prepn. method therefor |
Non-Patent Citations (4)
Title |
---|
提高大豆异黄酮活性作用的研究进展. 钱丽丽,张永忠,左锋.食品工业科技,第3期. 2005 |
提高大豆异黄酮活性作用的研究进展. 钱丽丽,张永忠,左锋.食品工业科技,第3期. 2005 * |
植物性食品中雌激素的化学结构和生理活性及在功能食品中的应用. 徐娟,陈爱英,单正明.食品科学,第23卷第9期. 2002 |
植物性食品中雌激素的化学结构和生理活性及在功能食品中的应用. 徐娟,陈爱英,单正明.食品科学,第23卷第9期. 2002 * |
Also Published As
Publication number | Publication date |
---|---|
WO2007147319A1 (en) | 2007-12-27 |
CN1895469A (en) | 2007-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107050189A (en) | A kind of lycium ruthenicum adds integration of drinking and medicinal herbs traditional Chinese medicine mate product and preparation method | |
CN101181058B (en) | Five-element fruit vegetables nutrition preparations for reinforcing human body five-organs function and preparation method thereof | |
MXPA06012501A (en) | Nutritional composition which promotes weight loss, burns calories, increases thermogenesis, supports energy metabolism and/or suppresses appetite. | |
Navarra | The encyclopedia of vitamins, minerals, and supplements | |
CN104336675A (en) | Black sesame and fructus lycii nutritious congee and preparation method | |
Yampolsky et al. | Dates (Phoenix dactylifera) | |
CN102318821A (en) | Special meal nutritional food applicable to males preparing to have baby | |
US20060269623A1 (en) | Herbal composition and method of use for promoting erections and treating erectile dysfunction in men | |
CN105249440A (en) | Donkey-hide gelatin cake | |
CN100490864C (en) | Yin-nourishing fatigue-relieving capsules | |
EP1637149A1 (en) | Dietary supplement composition for the man | |
CN112544767A (en) | Preparation method of selenium-rich tabletted candy | |
CN105056005B (en) | A kind of integration of drinking and medicinal herbs composition of energy lower blood-fat and reduce weight | |
CN109275905A (en) | The preparation method of one kind of multiple plant compounding nutritional supplements | |
US20230180810A1 (en) | Dosage forms and methods of preparation and use thereof | |
CN109549032A (en) | A kind of light body function beverage and preparation method thereof of losing weight | |
CN107693705A (en) | A kind of anti-aging, antifatigue Chinese medicine preparation and its application | |
Weed | Menopause and beyond: The wise woman way | |
CN111849688A (en) | Health-preserving wine and preparation process thereof | |
Puri et al. | Natural aphrodisiacs: myth or reality | |
Diwekar | Indian superfoods | |
KR20030087762A (en) | healthy cadence foodstuffs and that composion for increaing woman vitality | |
CN108883145A (en) | A kind of medicament for oral administration applying combined treatment AIDS, tumour outside | |
Petitto | Adaptogens: A Directory of Over 50 Healing Herbs for Energy, Stress Relief, Beauty, and Overall Well-being | |
Siddiqui et al. | Almond (Prunus amygdalus L.): A source of revitalizing health and its therapeutic application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: ZHAO WEI; APPLICANT Free format text: FORMER OWNER: YANGGUANG MEDICAL SCIENCE AND TECHNOLOGY CO., LTD., HUBEI Effective date: 20070622 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20070622 Address after: 430015, Sunshine Hotel, Jianghan Road, Jianghan District, Hubei, 222, Wuhan, 12 Applicant after: Zhao Wei Co-applicant after: Yang Yongguo Address before: 430025, Sunshine Hotel, Jianghan Road, Jianghan District, Hubei, 222, Wuhan, 12 Applicant before: HUBEI YANGGUANG SCIENTIFIC AND TECHNOLOGICAL MEDICINES Co.,Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: ZHAO WEI Free format text: FORMER NAME: HUBEI YANGGUANG PHARMACEUTICAL SCIENCE AND TECHNOLOGY CO., LTD. |
|
CP03 | Change of name, title or address |
Address after: No. 166 in Hubei province Wuhan City Donghu high tech Zone Gaoxin Avenue Patentee after: Zhao Wei Address before: Room 1204, Sunshine Hotel, 222 Xin Ha Road, Wuhan, Hubei Patentee before: HUBEI YANGGUANG SCIENTIFIC AND TECHNOLOGICAL MEDICINES Co.,Ltd. |
|
C57 | Notification of unclear or unknown address | ||
DD01 | Delivery of document by public notice |
Addressee: Zhao Wei Document name: Notification of Passing Examination on Formalities Addressee: Zhao Wei Document name: Approval notice for cost mitigation |
|
DD01 | Delivery of document by public notice |
Addressee: Zhao Wei Document name: Notification to Pay the Fees |
|
DD01 | Delivery of document by public notice |
Addressee: Zhao Wei Document name: Notification of Termination of Patent Right |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090527 Termination date: 20100616 |
|
RR01 | Reinstatement of patent right |
Former decision: cessation of patent right due to non-payment of the annual fee Former decision publication date: 20111012 |
|
DD01 | Delivery of document by public notice |
Addressee: Zhao Wei Document name: Notice of amendment Addressee: Zhao Wei Document name: Notification of Decision on Request for Restoration of Right |
|
DD01 | Delivery of document by public notice |
Addressee: Yuhuan Wuhan spring Biotechnology Co.,Ltd. Person in charge of patents Document name: Notification that Application Deemed not to be Proposed |
|
DD01 | Delivery of document by public notice |
Addressee: Zhao Wei Document name: Notification to Pay the Fees |
|
ASS | Succession or assignment of patent right |
Owner name: WUHAN YUHUANCHUN BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: ZHAO WEI Effective date: 20131025 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 430030 WUHAN, HUBEI PROVINCE TO: 430011 WUHAN, HUBEI PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20131025 Address after: 430011, building 888, building 4, building 10, Dai Cheng Shan science and Technology Town, No. 09 Huang Huang Road, Jiang'an Road, Hubei, Wuhan, 11, China. 07 Patentee after: Yuhuan Wuhan spring Biotechnology Co.,Ltd. Address before: 166 No. 430030 Hubei province Wuhan City Donghu high tech Zone Gaoxin Avenue Patentee before: Zhao Wei |
|
DD01 | Delivery of document by public notice |
Addressee: Zhao Wei Document name: Notification of Passing Examination on Formalities |
|
ASS | Succession or assignment of patent right |
Owner name: ZHAO WEI Free format text: FORMER OWNER: WUHAN YUHUANCHUN BIOTECHNOLOGY CO., LTD. Effective date: 20150511 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 430011 WUHAN, HUBEI PROVINCE TO: 430015 WUHAN, HUBEI PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150511 Address after: 430015 room 1203/1204, Sunshine Hotel, 222 Xinhua Road, Jianghan District, Hubei, Wuhan Patentee after: Zhao Wei Address before: 430011, building 888, building 4, building 10, Dai Cheng Shan science and Technology Town, No. 09 Huang Huang Road, Jiang'an Road, Hubei, Wuhan, 11, China. 07 Patentee before: Yuhuan Wuhan spring Biotechnology Co.,Ltd. |
|
DD01 | Delivery of document by public notice |
Addressee: Fu Ran Document name: Notification of Passing Examination on Formalities |
|
TR01 | Transfer of patent right |
Effective date of registration: 20190807 Address after: 430079 Room 409-02, Building B8, Phase 2, Wuhan Software New Town, No. 8 Huacheng Avenue, Donghu New Technology Development Zone, Wuhan City, Hubei Province Patentee after: Wuhan Creative Hero Culture Communication Co.,Ltd. Address before: 430015 room 1203/1204, Sunshine Hotel, 222 Xinhua Road, Jianghan District, Hubei, Wuhan Patentee before: Zhao Wei |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191111 Address after: 430079 floor 1, building C4, Optics Valley biology, No. 666, Gaoxin Avenue, Donghu New Technology Development Zone, Wuhan City, Hubei Province Patentee after: CHANGE INNOVATION (WUHAN) BIO-TECH Co.,Ltd. Address before: 430079 Room 409-02, Building B8, Phase 2, Wuhan Software New Town, No. 8 Huacheng Avenue, Donghu New Technology Development Zone, Wuhan City, Hubei Province Patentee before: Wuhan Creative Hero Culture Communication Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090527 |